Ge healthcare's carescape canvas patient monitoring platform receives fda clearance

Chicago--(business wire)--ge healthcare (nasdaq: gehc) today announced us fda 510(k) clearance of its carescape canvas patient monitoring platform for precise, flexible patient care. carescape canvas and carescape one are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service.
GEHC Ratings Summary
GEHC Quant Ranking